[go: up one dir, main page]

TW200635616A - Organic compounds - Google Patents

Organic compounds

Info

Publication number
TW200635616A
TW200635616A TW094143807A TW94143807A TW200635616A TW 200635616 A TW200635616 A TW 200635616A TW 094143807 A TW094143807 A TW 094143807A TW 94143807 A TW94143807 A TW 94143807A TW 200635616 A TW200635616 A TW 200635616A
Authority
TW
Taiwan
Prior art keywords
organic compounds
administered
animal
slow
human
Prior art date
Application number
TW094143807A
Other languages
Chinese (zh)
Other versions
TWI369218B (en
Inventor
Caroline Sautter
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of TW200635616A publication Critical patent/TW200635616A/en
Application granted granted Critical
Publication of TWI369218B publication Critical patent/TWI369218B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

The invention relates to a composition, comprising a thermoplastic polymer, a rate modifying agent and a biologically active agent, useful as a slow-release drug-delivery implant in the body of a human or animal that can be administered in liquid form into the body.
TW094143807A 2004-12-14 2005-12-12 In situ forming implant for animals TWI369218B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04029498 2004-12-14

Publications (2)

Publication Number Publication Date
TW200635616A true TW200635616A (en) 2006-10-16
TWI369218B TWI369218B (en) 2012-08-01

Family

ID=34927750

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094143807A TWI369218B (en) 2004-12-14 2005-12-12 In situ forming implant for animals

Country Status (16)

Country Link
JP (1) JP5372378B2 (en)
KR (1) KR101304160B1 (en)
CN (1) CN101056617B (en)
AR (1) AR052155A1 (en)
AT (1) ATE389386T1 (en)
AU (1) AU2005315823B2 (en)
BR (1) BRPI0519022A2 (en)
CA (1) CA2585779C (en)
DE (1) DE602005005522T2 (en)
ES (1) ES2301084T3 (en)
MX (1) MX2007007099A (en)
NZ (1) NZ554904A (en)
RU (1) RU2394558C2 (en)
TW (1) TWI369218B (en)
WO (1) WO2006063794A1 (en)
ZA (1) ZA200703506B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
CA2687979C (en) 2007-05-25 2017-07-04 Tolmar Therapeutics, Inc. Sustained delivery formulations of risperidone compounds
CN101159064B (en) 2007-11-29 2010-09-01 腾讯科技（深圳）有限公司 Image generation system and method for generating image
US9877973B2 (en) 2008-05-12 2018-01-30 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10588855B2 (en) 2008-05-12 2020-03-17 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
US10064819B2 (en) 2008-05-12 2018-09-04 University Of Utah Research Foundation Intraocular drug delivery device and associated methods
JP6543431B2 (en) * 2013-10-10 2019-07-10 ユニバーシティー オブ ユタ リサーチ ファウンデーションＵｎｉｖｅｒｓｉｔｙ ｏｆ Ｕｔａｈ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Intraocular drug delivery device and associated method
EP3609470B1 (en) * 2017-04-13 2023-11-22 Ceva Santé Animale Implant for treating parasites infestations
CN112336682B (en) * 2020-09-28 2022-07-08 浙江大学 Injectable composite carrier and composition with slow and controlled release drug effect and preparation method
JP2025521784A (en) 2022-06-30 2025-07-10 ヴィルバック Use of deslorelin in chemical castration of non-human mammals involving PK/PD interactions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4938763B1 (en) * 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
AU739469B2 (en) * 1996-12-20 2001-10-11 Alza Corporation Gel composition and methods
AU751861B2 (en) * 1998-02-23 2002-08-29 Massachusetts Institute Of Technology Biodegradable shape memory polymers
AU745841B2 (en) * 1998-03-19 2002-04-11 Merck Sharp & Dohme Corp. Liquid polymeric compositions for controlled release of bioactive substances
US7128927B1 (en) * 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
JP4317606B2 (en) * 1998-09-18 2009-08-19 サンスター株式会社 Solid particle forming composition
BR0315304A (en) * 2002-11-06 2005-08-16 Alza Corp Depot formulations for controlled release
CA2518791A1 (en) * 2003-03-11 2004-09-23 Qlt Usa Inc. Formulations for cell-schedule dependent anticancer agents

Also Published As

Publication number Publication date
AU2005315823A1 (en) 2006-06-22
DE602005005522T2 (en) 2009-04-16
AU2005315823B2 (en) 2009-06-04
CN101056617B (en) 2012-07-11
ZA200703506B (en) 2008-09-25
MX2007007099A (en) 2007-06-22
JP5372378B2 (en) 2013-12-18
BRPI0519022A2 (en) 2008-12-23
RU2007126759A (en) 2009-01-27
KR101304160B1 (en) 2013-09-04
JP2008523131A (en) 2008-07-03
KR20070092964A (en) 2007-09-14
ES2301084T3 (en) 2008-06-16
DE602005005522D1 (en) 2008-04-30
CN101056617A (en) 2007-10-17
TWI369218B (en) 2012-08-01
AR052155A1 (en) 2007-03-07
WO2006063794A1 (en) 2006-06-22
CA2585779C (en) 2014-01-28
NZ554904A (en) 2009-11-27
CA2585779A1 (en) 2006-06-22
RU2394558C2 (en) 2010-07-20
ATE389386T1 (en) 2008-04-15

Similar Documents

Publication Publication Date Title
WO2007038246A3 (en) Solid polymer delivery compositions and methods for use thereof
MXPA04008906A (en) Composition having gelling properties for the prolonged delivery of bioactive substances.
WO2006023130A3 (en) Biodegradable controlled release bioactive agent delivery device
WO2010039641A3 (en) Long term drug delivery devices with polyurethane-based polymers and their manufacture
WO2008108987A3 (en) Medical device with a porous surface for delivery of a therapeutic agent
ATE288258T1 (en) BIODEGRADABLE POLYMER COMPOSITION
TW200605870A (en) Topical methadone compositions and methods for using the same
MY143795A (en) Tetrahydropyridoindole derivatives
MX2009003504A (en) Device for local and/or regional delivery employing liquid formulations of therapeutic agents.
WO2005096990A3 (en) Novel modification of medical prostheses
MD20070267A (en) Gastroresistant pharmaceutical formulation containing rifaximin
WO2004052336A3 (en) High viscosity liquid controlled delivery system and medical or surgical device
MX2010005629A (en) Pharmaceutical preparation for treating benign prostatic hyperplasia.
TW200716628A (en) Novel compounds
WO2008151040A3 (en) Analgesic coated medical product
IL188176A0 (en) Stable pharmaceutical composition comprising linezolid form iv
TW200635616A (en) Organic compounds
MXPA05012768A (en) Implantable polymeric device for sustained release of nalmefene.
BG108870A (en) Sustained/controlled release solid formulation as a novel drug delivery system with reduced risk of dose dumping
TW200630128A (en) Active ingredient-containing silicone elastomers
EP1503748A4 (en) Drugs for mitigating taxane-induced neurotoxicity
GB2443793B (en) Product, method of manufacture and use
MX2009001231A (en) Subcutaneous implants releasing an active principle over an extended period of time.
WO2006121522A3 (en) Implantable sensors and pumps, anti-scarring agents, and therapeutic compositions
WO2006138571A3 (en) Composition and methods for treating complications associated with ingestion of a medicinal, chemical or biological substance

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees